Comments*

 
  • Multiple Sclerosis

    Diagnostic and Treatment Frontiers

    Multiple Sclerosis

    Diagnostic and Treatment Frontiers

    Keynote Speakers: Barry G. Arnason, MD (University of Chicago) and Giancarlo Comi, MD (Università Vita-Salute San Raffaele)Presented by the New York Academy of Sciences
    Reported by Megan Stephan | Posted January 13, 2017

    Overview

    Multiple sclerosis (MS) is an unpredictable autoimmune disorder with multiple, often disabling neurologic symptoms. Although many patients live nearly normal life spans, the consequences for quality of life can be profound. MS has a strong genetic component, but as yet unknown environmental factors are thought to trigger the disorder in susceptible individuals. In recent years, clinical and basic science researchers have made inroads into understanding this challenging disorder, with the hopes of improving clinicians' abilities to diagnose, assess risk, and select individualized treatment regimens for their patients. Multiple new therapies have been developed and approved, and more are on the way. On June 28th, 2016, the Academy presented Multiple Sclerosis: Diagnostic and Treatment Frontiers featuring a discussion of the current state of and future prospects for research on MS, including cutting edge genetics approaches and novel insights into the molecular pathophysiology of this complex disease.

    Use the tabs above to find a meeting report and multimedia from this event.

    Presentations available from:
    Barry G. Arnason, MD (University of Chicago)
    Giancarlo Comi, MD, (Università Vita-Salute San Raffaele)
    Philip L. De Jager, MD, PhD (Brigham and Women's Hospital, Harvard University; Broad Institute of Harvard and Massachusetts Institute of Technology)
    Susan A. Gauthier, DO, MPH (Weill Cornell Medical College)
    David A. Hafler, MD, MSc (Yale School of Medicine; Broad Institute of Harvard and Massachusetts Institute of Technology)
    Fred D. Lublin, MD (Icahn School of Medicine at Mount Sinai)
    Darin Okuda, MD (University of Texas Southwestern Medical Center)
    Eric Thouvenot, MD, PhD (Université Montpellier)


    Presented by

    The New York Academy of Sciences

    Platinum Sponsor

    Teva CNS


    How to cite this eBriefing

    The New York Academy of Sciences. Multiple Sclerosis: Diagnostic and Treatment Frontiers. Academy eBriefings. 2016. Available at: www.nyas.org/MS2016-eB

    EmailPrint